NEUROFIBROMATOSIS 1

Clinical trials for NEUROFIBROMATOSIS 1 explained in plain language.

Never miss a new study

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

Sign up with your email to follow new studies for NEUROFIBROMATOSIS 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 8 Completed 7

New drug cocktail aims to shrink NF1 tumors

Disease control Not yet recruiting

This early-stage trial tests whether two cancer drugs, cabozantinib and selumetinib, can safely shrink plexiform neurofibromas in people aged 16 and older with neurofibromatosis type 1 (NF1). About 30 participants will receive the combination daily. The study first finds the safe…

Matched conditions: NEUROFIBROMATOSIS 1

Phase: PHASE1 • Sponsor: Girish Dhall, MD • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC

NEUROFIBROMATOSIS 1

Get alerted when new NEUROFIBROMATOSIS 1 trials appear

New drug cocktail aims to shrink NF1 tumors